Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
breast cancer genomic test
|
| gptkbp:analyzes |
gene expression in breast tumor tissue
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:basedOn |
PAM50 gene signature
|
| gptkbp:CEMarked |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Prosigna
|
| gptkbp:manufacturer |
gptkb:NanoString_Technologies
|
| gptkbp:provides |
intrinsic breast cancer subtype classification
risk of recurrence score |
| gptkbp:type |
in vitro diagnostic
formalin-fixed, paraffin-embedded tissue |
| gptkbp:usedFor |
postmenopausal women with early-stage breast cancer
assessing risk of breast cancer recurrence |
| gptkbp:usedIn |
clinical decision making
|
| gptkbp:bfsParent |
gptkb:MammaPrint
|
| gptkbp:bfsLayer |
7
|